XML 86 R49.htm IDEA: XBRL DOCUMENT v3.25.1
Income Tax (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax [Abstract]  
Schedule of Income Tax Expense

The income tax expense of the company for the Relevant Periods is analyzed as follows:

 

   Year ended December 31, 
   2022   2023   2024 
       revised     
   $’000   $’000   $’000 
Current   
    
 —
    
 —
 
Deferred   
    
    
 
Total   
    
    
 
Schedule of Reconciliation of the Tax Expense Applicable to Loss Before Tax at the Statutory Rate to the Tax Expense at the Effective Tax Rate

A reconciliation of the tax expense applicable to loss before tax at the statutory rate to the tax expense at the effective tax rate is as follows:

 

   Year ended December 31, 
   2022   2023   2024 
       revised     
   $’000   $’000   $’000 
Loss before tax   (58,790)   (109,228)   (51,869)
Tax at the statutory tax rate (25%)   (14,698)   (27,307)   (12,967)
Foreign rate differential   2,933    15,111    3,349 
Expenses not deductible for tax   2,171    126    92 
Income not subject to tax   (4)   
    
 
Additional deductible allowance for qualified research and development costs   (1,681)   (2,338)   (1,506)
Non tax-effective share-based payments   
    
    2,150 
Unrecognized deferred tax assets   11,279    14,408    8,882 
Current income tax expense   
    
    
 
Tax charge at the Group’s effective rate   
    
    
%
Schedule of Deferred Tax Assets

A deferred tax asset has not been recognised for the following:

 

   Year ended December 31 
   2023   2024 
   revised     
   $’000   $’000 
Deductible temporary differences   13,306    14,080 
Unused tax losses   29,876    37,984 
Total   43,182    52,064